Evidence map›Paper›PMID 41762342›Full record

ReviewWorld journal of microbiology & biotechnology2026

A comprehensive analysis of the kinetics of infection of lytic bacteriophages specific to the ESKAPE and critical pathogens.

Olaf Bajrak, Martyna Cieślik, Andrzej Górski, Ewa Jończyk-Matysiak

Abstract readReview
In one paragraph

Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Olaf BajrakBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), Wrocław, Poland.
Martyna CieślikBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), Wrocław, Poland.
Andrzej GórskiBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), Wrocław, Poland.
Ewa Jończyk-MatysiakBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), Wrocław, Poland. ewa.jonczyk-matysiak@hirszfeld.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages are ubiquitous particles that are able to infect bacterial and archaeal cells and may serve as an antimicrobial agent. Herein, a scoping review of strictly lytic bacteriophages infecting bacteria belonging to the ESKAPE group and critical pathogens is proposed in order to summarize information about their biological characteristics in vitro. The data collected herein will be useful for the rapid in vitro characterization of newly isolated phages, facilitating their likely effective use in phage therapy and allowing them to be compared with previously described phages of the same specificity. Data were obtained from original, peer-reviewed, full-length scientific articles published between 1998 and 2025, available in the PubMed database, focusing on the analysis of phage infection kinetics (adsorption rate and parameters derived from one-step growth experiments). However, additional features, including morphology of their plaques (like the presence or absence of a ‘halo’ effect), type of morphology of phage virions or lytic spectrum have also been included, in order to relate acquired data regarding to phage replication cycle kinetics to the mentioned phage characteristics.

Indexed as

BacteriaBacteriophagesKineticsPhage TherapyVirionVirus ReplicationCycle parametersESKAPE groupLytic bacteriophage

Identifiers

PMID41762342
PMCPMC12950090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.